Acute heart failure: mechanisms and pre-clinical models-a Scientific Statement of the ESC Working Group on Myocardial Function

Autores da FMUP
Participantes de fora da FMUP
- Ciccarelli, M
- Bauersachs, J
- Bertrand, L
- Beauloye, C
- Dawson, D
- Hamdani, N
- Hilfiker-Kleiner, D
- van Laake, LW
- Lezoualc'h, F
- Linke, WA
- Lunde, IG
- Rainer, PP
- Rispoli, A
- Visco, V
- Carrizzo, A
- Dal Ferro, M
- Stolfo, D
- van der Velden, J
- Zacchigna, S
- Heymans, S
- Thum, T
- Tocchetti, CG
Unidades de investigação
Abstract
While chronic heart failure (CHF) treatment has considerably improved patient prognosis and survival, the therapeutic management of acute heart failure (AHF) has remained virtually unchanged in the last decades. This is partly due to the scarcity of pre-clinical models for the pathophysiological assessment and, consequently, the limited knowledge of molecular mechanisms involved in the different AHF phenotypes. This scientific statement outlines the different trajectories from acute to CHF originating from the interaction between aetiology, genetic and environmental factors, and comorbidities. Furthermore, we discuss the potential molecular targets capable of unveiling new therapeutic perspectives to improve the outcome of the acute phase and counteracting the evolution towards CHF. Graphical Abstract Assembling the acute heart failure (AHF) in a translational view. Different causes of AHF can be reproduced in pre-clinical models to unveil novel pathophysiological and molecular mechanisms. Identifying novel molecular targets amongst organelles and cellular compartments can be tested again in the pre-clinical models. Effective strategies can be exploited in human scenarios. Image was partially created with BioRender.com.
Dados da publicação
- ISSN/ISSNe:
- 1755-3245, 0008-6363
- Tipo:
- Review
- Páginas:
- 2390-2404
- DOI:
- 10.1093/cvr/cvad088
Cardiovascular Research Oxford University Press
Citações Recebidas na Web of Science: 1
Documentos
- Não há documentos
Filiações
Keywords
- Acute heart failure; Phenotypes; Trajectories; Pre-clinical models; Therapeutic management; Scientific statement; New strategies
Financiamento
Proyectos asociados
Cardiac Remodelling and “Recovery” in Pregnancy as a Model to Understand the Mechanisms of CV Diseases.
Investigador Principal: Inês Maria Falcão Sousa Pires Marques
Estudo Observacional Académico (PERIMYR) . SP Cardiologia . 2019
Remodelling adversely impacts arrhythmic outcome following isolated aortic valve replacement surgery
Investigador Principal: Inês Maria Falcão Sousa Pires Marques
Estudo Clínico Académico (Remodelling) . 2020
Potencial Role of microRNAs as biomakers and therapeutic targets during left ventricular reverse remodelling
Investigador Principal: Inês Maria Falcão Sousa Pires Marques
Estudo Clínico Académico . 2022
The cross-talk between adipose tissue and heart
Investigador Principal: Inês Maria Falcão Sousa Pires Marques
Estudo Clínico Académico . 2022
The Heart under Pressure: Mechanisms underlying HEpEF Secondary to chronic pressure Overload or Metabolic Syndrome
Investigador Principal: Inês Maria Falcão Sousa Pires Marques
Estudo Clínico Académico . 2020
Citar a publicação
Ciccarelli M,Pires IF,Bauersachs J,Bertrand L,Beauloye C,Dawson D,Hamdani N,Hilfiker D,van LW,Lezoualc'h F,Linke WA,Lunde IG,Rainer PP,Rispoli A,Visco V,Carrizzo A,Dal M,Stolfo D,van der Velden J,Zacchigna S,Heymans S,Thum T,Tocchetti CG. Acute heart failure: mechanisms and pre-clinical models-a Scientific Statement of the ESC Working Group on Myocardial Function. Cardiovasc. Res. 2023. 119(14):p. 2390-2404. IF:10,800. (1).